Can I read Artigo - Lenacapavir A First-In-class Capsid Inhibitor For HIV Treatment and Prevention on EtoBox?

Artigo - Lenacapavir A First-In-class Capsid Inhibitor For HIV Treatment and Prevention by pedrohbromagnoli is a document available to read on EtoBox.

What is Artigo - Lenacapavir A First-In-class Capsid Inhibitor For HIV Treatment and Prevention about?

Lenacapavir (LEN) is a first-in-class capsid inhibitor approved for treating multidrug-resistant HIV, with a unique mechanism that targets multiple stages of the viral lifecycle. It is administered subcutaneously every 6 months and has shown high efficacy in clinical trials for both treatment and prevention, particularly in vulnerable populations. However, its widespread adoption faces challenges such as high costs and the need for effective long-acting combination therapies.

Author

pedrohbromagnoli

Language

EN